Inspire Medical Systems has filed a patent for methods and devices to identify disease burden indicators. The patent focuses on sleep disordered breathing and related parameters, which can be detected using implantable sensors like an acceleration sensor. The patent claim describes a method that involves sensing physiologic information through a sensor and using this information to identify a disease burden indicator. GlobalData’s report on Inspire Medical Systems gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inspire Medical Systems, Cardiac activity monitoring wearables was a key innovation area identified from patents. Inspire Medical Systems's grant share as of September 2023 was 41%. Grant share is based on the ratio of number of grants to total number of patents.
Method for identifying disease burden indicator using physiologic information
A recently filed patent (Publication Number: US20230277121A1) describes a method for sensing physiologic information using a sensor and identifying a disease burden indicator based on the sensed information. The patent claims to offer a novel approach to monitoring and assessing disease burden.
The first claim of the patent outlines the method, which involves using a sensor to gather physiologic information from an individual. This information could include data related to heart rate, blood pressure, temperature, or other relevant indicators. The patent suggests that by analyzing this physiologic information, it is possible to identify a disease burden indicator. This indicator could potentially provide valuable insights into the severity or progression of a disease.
The patent does not provide specific details about the types of diseases or conditions that can be assessed using this method. However, it suggests that the approach could be applicable to a wide range of health conditions. By monitoring physiologic information and identifying disease burden indicators, healthcare professionals may be able to make more informed decisions regarding treatment plans and interventions.
It is important to note that the patent does not provide any evidence or data to support the effectiveness or accuracy of the proposed method. As with any patent, further research and validation would be necessary to determine the practicality and reliability of this approach.
In conclusion, the filed patent (Publication Number: US20230277121A1) describes a method for sensing physiologic information and identifying disease burden indicators. While the patent claims to offer a novel approach to monitoring and assessing disease burden, further research and validation would be required to determine its effectiveness and practicality in real-world applications.
To know more about GlobalData’s detailed insights on Inspire Medical Systems, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
